Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,828 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression.
Diossy M, Tisza V, Li H, Sahgal P, Zhou J, Sztupinszki Z, Young D, Nousome D, Kuo C, Jiang J, Chen Y, Ebner R, Sesterhenn IA, Moncur JT, Chesnut GT, Petrovics G, Klus GT, Valcz G, Nuzzo PV, Ribli D, Börcsök J, Prosz A, Krzystanek M, Ried T, Szuts D, Rizwan K, Kaochar S, Pathania S, D'Andrea AD, Csabai I, Srivastava S, Freedman ML, Dobi A, Spisak S, Szallasi Z. Diossy M, et al. Among authors: kuo c. NPJ Precis Oncol. 2024 Sep 19;8(1):208. doi: 10.1038/s41698-024-00705-8. NPJ Precis Oncol. 2024. PMID: 39294262 Free PMC article.
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiency.
Szallasi Z, Diossy M, Tisza V, Li H, Sahgal P, Zhou J, Sztupinszki Z, Young D, Nuosome D, Kuo C, Jiang J, Chen Y, Ebner R, Sesterhenn I, Moncur J, Chesnut G, Petrovics G, T Klus G, Valcz G, Nuzzo P, Ribli D, Börcsök J, Prósz A, Krzystanek M, Ried T, Szüts D, Rizwan K, Kaochar S, Pathania S, D'Andrea A, Csabai I, Srivastava S, Freedman M, Dobi A, Spisak S. Szallasi Z, et al. Among authors: kuo c. Res Sq [Preprint]. 2024 Apr 1:rs.3.rs-3995251. doi: 10.21203/rs.3.rs-3995251/v1. Res Sq. 2024. Update in: NPJ Precis Oncol. 2024 Sep 19;8(1):208. doi: 10.1038/s41698-024-00705-8 PMID: 38645014 Free PMC article. Updated. Preprint.
Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer.
Sharad S, Sztupinszki ZM, Chen Y, Kuo C, Ravindranath L, Szallasi Z, Petrovics G, Sreenath TL, Dobi A, Rosner IL, Srinivasan A, Srivastava S, Cullen J, Li H. Sharad S, et al. Among authors: kuo c. Cancers (Basel). 2019 Dec 12;11(12):1995. doi: 10.3390/cancers11121995. Cancers (Basel). 2019. PMID: 31842254 Free PMC article.
Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression.
Gao Y, Wang YT, Chen Y, Wang H, Young D, Shi T, Song Y, Schepmoes AA, Kuo C, Fillmore TL, Qian WJ, Smith RD, Srivastava S, Kagan J, Dobi A, Sesterhenn IA, Rosner IL, Petrovics G, Rodland KD, Srivastava S, Cullen J, Liu T. Gao Y, et al. Among authors: kuo c. Cancers (Basel). 2020 May 17;12(5):1268. doi: 10.3390/cancers12051268. Cancers (Basel). 2020. PMID: 32429558 Free PMC article.
A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy.
Caumont F, Conti G, Hurwitz LM, Kuo C, Levie KE, Badiozamani K, Frankel JK, Flores JP, Brand TC, Chaurasia A, Rosner IL, Stroup SP, Musser JE, Cullen J, Porter CR. Caumont F, et al. Among authors: kuo c. Urol Oncol. 2020 Oct;38(10):794.e1-794.e9. doi: 10.1016/j.urolonc.2020.02.007. Epub 2020 Mar 3. Urol Oncol. 2020. PMID: 32139288
7,828 results